This process, in turn, suppresses the nuclear factor-κB (NF-κB)-mediated transcriptional activation, thereby reducing the production of interleukin 8 (IL-8) and limiting the proliferation of prostate cancer cells [28]. The gene discussed is CXCL8; the disease is prostate carcinoma.